Last reviewed · How we verify
Allergic conjunctivitis
Approved treatments
- Temaril
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxylamin · St. Petersburg Bekhterev Research Psychoneurological Institute
- Drixoral · Merck & Co.
- Hispril · GSK
- Pyribenzamin · Novartis
- Pyrilamine · Impax Labs
- Semprex-D · Auxilium Pharms Inc
- Propadrine · Alpharma Us Pharms
- Phenazoline · Novartis
- Lotemax · Bausch Health
- Tobi · Novartis
- Fml · AbbVie
- Tussionex Pennkinetic · Bayer
- Emadine · Novartis
- Hydroxyzine Hydrochloride · Pfizer
- Medrifar · AbbVie
- Tazanol
Tazanolast works by inhibiting the action of a specific enzyme involved in the allergic response. - Allegra · Generic (originally Hoechst Marion Roussel/Sanofi)
- Zaditor
- Cyproheptadine Hydrochloride
- Alocril · AbbVie
- Unisom · Chattem
- Cortone
- Tham · Pfizer
- Intal · Pfizer
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Marezine · GSK
- Seldane
- Zepelin
Acitazanolast works by blocking the action of mast cells, which are involved in the allergic response. - Sudafed PE · Generic (multiple manufacturers)
- Phencarol
Phencarol works by blocking the action of histamine, a chemical released by the body during an allergic reaction. - Hismanal
- Perazyl
- Benadryl · Brooke Army Medical Center
- Phenergan Vc W/ Codeine · ANI Pharmaceuticals
- Vantobra · Pfizer
- Cromoglicate · LEO Pharma
- Benadryl · Johnson & Johnson (McNeil Consumer Healthcare)
- Nebcin · University Hospital, Lille
- Zyrtec · Generic (originally UCB Pharma)
- pecazine
- Akovaz
Akovaz works by releasing norepinephrine, a natural chemical in the body that helps to relieve symptoms of respiratory and allergic conditions. - Cortef · Generic (originally Merck/Upjohn)
- Rhinol
Rhinol works by activating the alpha-2A adrenergic receptor to constrict blood vessels in the nasal passages. - Bepreve · Bausch Health
Bepotastine blocks H1 receptors and inhibits histamine release from mast cells. - Patanol · ORA, Inc.
- Clarinex · Generic (originally Schering-Plough/MSD)
Active metabolite of loratadine with higher potency at H1 receptors and additional anti-inflammatory properties. - Claritin · Generic (originally Schering-Plough)
Clinical guidelines
- FDA label — 1L
Dexamethasone is indicated for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment. - FDA label — 1L
Dexamethasone is indicated for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment. - FDA label — 1L
Dexamethasone is indicated for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment. - FDA label — 1L
Dexamethasone is indicated for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Allergic conjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Allergic conjunctivitis treatment landscape brief
- Allergic conjunctivitis treatment updates RSS
Frequently asked questions about Allergic conjunctivitis
What drugs treat Allergic conjunctivitis?
Tracked treatments include Temaril, Ramycin, Doxylamin, Drixoral, Hispril, Pyribenzamin, Pyrilamine, Semprex-D.
What is the treatment for Allergic conjunctivitis?
Standard treatment for Allergic conjunctivitis includes Temaril, Ramycin, Doxylamin, Drixoral, Hispril. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Allergic conjunctivitis?
FDA label publishes guidelines for Allergic conjunctivitis. 4 guideline references tracked.
Related
- Treatment landscape: Allergic conjunctivitis patent cliff · Allergic conjunctivitis CI report
- Treatment: Temaril
- Treatment: Ramycin
- Treatment: Doxylamin · St. Petersburg Bekhterev Research Psychoneurological Institute
- Treatment: Drixoral · Merck & Co.
- Treatment: Hispril · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing